Form D · Biotechnology
Wobble Genomics Ltd
Edinburgh, X0 · CIK 0002005309
Offering snapshot reported Jan 5, 2024 · SEC filing
- Reported sold
- $254K Offering amount: $254K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2024 | Initial | $254,296 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-501679
Source: Form D, filed Jan 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicola Ann Broughton | Director |
| John Robert Fraser Duncan | Director |
| Richard Izen Kuo | Director, Executive |
| John Harris Leamon | Director |
| Lee James Lindley | Director |
| Iq Capital Directors Nominees Ltd | Director |
| Trevor John Nicholls | Director |
| Joanna Smart | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Suite 2, Ground Floor Orchard Brae House 30 Queensferry Road
Edinburgh, X0, EH4 2HS
Edinburgh, X0, EH4 2HS